While discussing the challenges of developing HIV vaccines, Louis Picker, M.D., says that while the cytomegalovirus-based vaccine platform he has spent 20 years developing may not work for HIV, it might be able to prevent other diseases. Picker says: “I think this technology is going to really come through for the medical community overall.”

While explaining the importance of protein in a balanced diet, Diane Stadler, R.D., notes plant-based proteins contain less saturated fats than animal-based proteins, adding: “Animal-based proteins lack some important nutrients like fiber, which is important to gastrointestinal function and health.”

A report on an incident involving alleged criminal mistreatment of a toddler at the OHSU Rood Family Pavilion.

A report on an incident involving alleged criminal mistreatment of a toddler at the OHSU Rood Family Pavilion.

Doctors, nurses and physician assistants at Legacy Health announce they plan to unionize, citing in part the proposed integration of Legacy by OHSU.

Doctors, nurses and physician assistants at Legacy Health announce they plan to unionize, citing in part the proposed integration of Legacy by OHSU.

KPTV-TV highlights medication lockboxes available at the OHSU Doernbecher Tom Sargent Safety Resource Center in a story about Suicide Prevention Month. Kyle Johnson, M.D., says, “Here at Doernbecher Children’s Hospital, we access many kids each month who have attempted suicide and 90% of kids have attempted suicide by taking overdoses of medicine. The mass majority of those medicines are ones that are readily available at home.”

The Portland Business Journal reports that OHSU picked up the lion’s share of NIH funding in Oregon in 2022 with $289 million — over half of the total funding awarded to all Oregon research institutions, private companies and nonprofit organizations combined.

The Portland Business Journal reports that OHSU picked up the lion’s share of NIH funding in Oregon in 2022 with $289 million — over half of the total funding awarded to all Oregon research institutions, private companies and nonprofit organizations combined.

OHSU is one of the clinical teams involved in a newly published study of drug candidates used in patients with phenylketonuria, or PKU.